Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer mortality, despite significant improvements in diagnostic imaging and operative mortality rates. The 5-year survival rate remains less than 5% because of microscopic or gross metastatic disease at time of diagnosis. The Cl...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Philip, Philip A., Mooney, Margaret, Jaffe, Deborah, Eckhardt, Gail, Moore, Malcolm, Meropol, Neal, Emens, Leisha, O'Reilly, Eileen, Korc, Murray, Ellis, Lee, Benedetti, Jacqueline, Rothenberg, Mace, Willett, Christopher, Tempero, Margaret, Lowy, Andrew, Abbruzzese, James, Simeone, Diane, Hingorani, Sunil, Berlin, Jordan, Tepper, Joel
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2009
主題:
Special Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7587401/
https://ncbi.nlm.nih.gov/pubmed/19858397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.9022
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料